These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30933052)

  • 1. Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer.
    Canale M; Marisi G; Passardi A; Scarpi E; Ulivi P
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
    Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
    Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer.
    Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of reference genes for circulating microRNA analysis in colorectal cancer.
    Niu Y; Wu Y; Huang J; Li Q; Kang K; Qu J; Li F; Gou D
    Sci Rep; 2016 Oct; 6():35611. PubMed ID: 27759076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
    Bell E; Watson HL; Bailey S; Murray MJ; Coleman N
    Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer.
    Alves Dos Santos K; Clemente Dos Santos IC; Santos Silva C; Gomes Ribeiro H; de Farias Domingos I; Nogueira Silbiger V
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
    Kloten V; Neumann MHD; Di Pasquale F; Sprenger-Haussels M; Shaffer JM; Schlumpberger M; Herdean A; Betsou F; Ammerlaan W; Af Hällström T; Serkkola E; Forsman T; Lianidou E; Sjöback R; Kubista M; Bender S; Lampignano R; Krahn T; Schlange T;
    Clin Chem; 2019 Sep; 65(9):1132-1140. PubMed ID: 31235535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
    Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations.
    ElSharawy A; Röder C; Becker T; Habermann JK; Schreiber S; Rosenstiel P; Kalthoff H
    Oncotarget; 2016 Nov; 7(46):75353-75365. PubMed ID: 27683108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers.
    Gherman A; Balacescu L; Gheorghe-Cetean S; Vlad C; Balacescu O; Irimie A; Lisencu C
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.
    Murray MJ; Watson HL; Ward D; Bailey S; Ferraresso M; Nicholson JC; Gnanapragasam VJ; Thomas B; Scarpini CG; Coleman N
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):208-218. PubMed ID: 29254935
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.